Validation of a Questionnaire to Measure Cough Severity

September 9, 2025 updated by: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Validation of a Questionnaire to Measure Cough Severity in Patients With Chronic Cough

To design and validate a questionnaire that allows objective assessment of the severity of chronic cough

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Chronic cough is a common disease that has important consequences for patients, ranging from physical to psychological and social aspects. However, there is currently no tool to objectively validate cough severity.

The aim of the study is to design and validate a questionnaire to objectively assess the severity of chronic cough.

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • Spain
      • Barcelona, Spain, 08003
        • Recruiting
        • Hospital del Mar
        • Contact:
      • Barcelona, Spain, 08036
        • Recruiting
        • Hospital Clinic de Barcelona
        • Contact:
      • Barcelona, Spain, 08041
        • Recruiting
        • Hospital de la Santa Creu i Sant Pau. Carrer Mas Casanovas 90.
        • Contact:
    • Barcelona
      • Badalona, Barcelona, Spain, 08916
        • Enrolling by invitation
        • Hospital Universitario Hermanos Trias y Pujol
      • L'Hospitalet de Llobregat, Barcelona, Spain, 08907
      • Sabadell, Barcelona, Spain, 08208
        • Recruiting
        • Parc Tauli Hospital Universitari
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Spanish-speaking patients with previous diagnosis of chronic cough or healthy volunteers.

Description

Inclusion Criteria:

  • Aged between 30 and 99 years
  • Clinical diagnosis of chronic cough or healthy volunteers
  • Good understanding of Spanish

Exclusion Criteria:

  • Non-Spanish-speaking patients
  • Inability to complete the questionnaires
  • Failure to sign the informed consent form

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Questionnaire
Chronic cough
Other: Questionnaire
Chronic cough questionnaire

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
A questionnaire for assessing the severity of chronic cough
Time Frame: 1 year
To design and validate a questionnaire to objectively assess the severity of chronic cough
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Correlation of the results of the questionnaire with frequency of cough
Time Frame: 1 year
Perform a statistical analysis to determine the correlation of the results of the questionnaire with frequency of cough
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Investigators

  • Principal Investigator: Astrid Crespo-Lessmann, PhD, Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2025

Primary Completion (Estimated)

November 1, 2025

Study Completion (Estimated)

April 1, 2026

Study Registration Dates

First Submitted

October 31, 2024

First Submitted That Met QC Criteria

October 31, 2024

First Posted (Actual)

November 1, 2024

Study Record Updates

Last Update Posted (Estimated)

September 15, 2025

Last Update Submitted That Met QC Criteria

September 9, 2025

Last Verified

October 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IIBSP-TOS-2023-133

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cough

Clinical Trials on Questionnaire

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Austria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe